Trade Mark Journal No.2025/041 10 October 2025

WO0000001877250 (5,42,44)

Office of origin: United States of America

Date of International Registration:19 August 2025
Date of designation in the UK: 19 August 2025
Image for mark 1877250 COHERUS ONCOLOGY

International priority date claimed: 17 July 2025 (United States of America) (99289852)
International priority date claimed: 21 July 2025 (United States of America) (99294479)
Class 5
Pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the treatment of oncologic diseases and disorders.
Class 42
Pharmaceutical research and development; consulting services in the field of biotechnology; consulting services in the field of pharmaceutical research and development; medical research; medical research services in the field of cancer; medical research in the field of oncology; research and development of pharmaceuticals for the treatment of cancer; providing information about medical research in the field of cancer.
Class 44
Medical information; providing information in the field of medicine; consulting services in the field of medical care; providing health information; providing health information in the field of cancer treatment; providing information in the field of cancer prevention, screening, diagnosis and treatment.

Coherus Oncology, Inc.

Representative: Perry J. Viscounty LATHAM & WATKINS LLP, 650 TOWN CENTER DRIVE, SUITE 2000, COSTA MESA CA 92626, UNITED STATES OF AMERICA